News

Molecules that build coenzyme Q10, vital for mitochondrial function, healed mice and a patient with an ultra-rare and lethal ...
As early-onset cancers rise, more people are faced with the question of how their treatment might affect their ability to ...
Where others see a natural air purifier, Ralf Reski, a plant biotechnologist at the University of Freiburg, saw untapped ...
However; single nucleotide polymorphism (SNP) genotyping often remains dependent on arrays, leaving genotyping and NGS ...
A surprise tickle attack, especially in sensitive areas like the armpits, torso, or soles of the feet, can send most people ...
After years of debate, scientists provided new evidence for the lifelong birth of human brain cells, which may inform future ...
A specially designed microbe cuts dietary methylmercury levels in pregnant mice, signaling the potential for a new tool for ...
Collagen IV provides crucial structural support for cells and tissues, but it’s unstable at body temperature. Researchers now ...
This webinar will be hosted live and available on-demand Tuesday, July 15th, 2025 11:00 AM - 12:30 PM ET Diverse microbial communities that dwell deep within the enclaves of the human gut and lungs ...
A new incubator shaker tackles the challenges of mammalian shake flask cultures with structural protection and expedited ...
Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to develop new therapies for age driven diseases, today announced the results of a new study detailing an ...
More drugs in development are failing to make it to market, according to Acting FDA Commissioner Lester M. Crawford. Historically, 14% of drugs entering Phase I have won approval, Crawford said in a ...